Literature DB >> 15889990

ELISA as a possible alternative to the neutralization test for evaluating the immune response to poliovirus vaccines.

Alexander P Ivanov1, Eugenia M Dragunsky.   

Abstract

This review describes several enzyme-linked immunosorbent assay (ELISA) techniques proposed to replace the neutralization test for detecting neutralization-relevant antibodies to polioviruses in recipients of inactivated poliovirus vaccine and oral poliovirus vaccine, and for seroepidemiologic studies. Comparisons of results from ELISA and the neutralization test suggest that ELISA variants, based on the principle of blocking or binding inhibition that emulate the neutralization test, might offer an alternative to the neutralization test. However, to replace the neutralization test with ELISA would first require extensive studies with very large numbers of serum samples, including sera having low titers of neutralizing antibodies, in order to obtain reliable and statistically sound validation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15889990     DOI: 10.1586/14760584.4.2.167

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN: 1476-0584            Impact factor:   5.217


  11 in total

1.  Chimpanzee-human monoclonal antibodies for treatment of chronic poliovirus excretors and emergency postexposure prophylaxis.

Authors:  Zhaochun Chen; Konstantin Chumakov; Eugenia Dragunsky; Diana Kouiavskaia; Michelle Makiya; Alexander Neverov; Gennady Rezapkin; Andrew Sebrell; Robert Purcell
Journal:  J Virol       Date:  2011-02-23       Impact factor: 5.103

2.  Antigenic evolution of vaccine-derived polioviruses: changes in individual epitopes and relative stability of the overall immunological properties.

Authors:  Maria L Yakovenko; Elena A Cherkasova; Gennady V Rezapkin; Olga E Ivanova; Alexander P Ivanov; Tatyana P Eremeeva; Olga Y Baykova; Konstantin M Chumakov; Vadim I Agol
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

3.  Development of an enzyme-linked immunosorbent spot assay to measure serum-neutralizing antibodies against coxsackievirus B3.

Authors:  Lisheng Yang; Delei He; Min Tang; Zhiqun Li; Che Liu; Longfa Xu; Yixin Chen; Hailian Du; Qinjian Zhao; Jun Zhang; Tong Cheng; Ningshao Xia
Journal:  Clin Vaccine Immunol       Date:  2014-01-03

4.  Inducing dose sparing with inactivated polio virus formulated in adjuvant CAF01.

Authors:  Jes Dietrich; Lars Vibe Andreasen; Peter Andersen; Else Marie Agger
Journal:  PLoS One       Date:  2014-06-23       Impact factor: 3.240

5.  MicroRNA screening identifies miR-134 as a regulator of poliovirus and enterovirus 71 infection.

Authors:  Nichole Lynn Orr-Burks; Byoung-Shik Shim; Weilin Wu; Abhijeet A Bakre; Jon Karpilow; Ralph A Tripp
Journal:  Sci Data       Date:  2017-03-01       Impact factor: 6.444

Review 6.  OMIC Technologies and Vaccine Development: From the Identification of Vulnerable Individuals to the Formulation of Invulnerable Vaccines.

Authors:  Nicola Cotugno; Alessandra Ruggiero; Veronica Santilli; Emma Concetta Manno; Salvatore Rocca; Sonia Zicari; Donato Amodio; Manuela Colucci; Paolo Rossi; Ofer Levy; Federico Martinon-Torres; Andrew J Pollard; Paolo Palma
Journal:  J Immunol Res       Date:  2019-04-28       Impact factor: 4.818

7.  Effect of HIV-exposure and timing of anti-retroviral treatment on immunogenicity of trivalent live-attenuated polio vaccine in infants.

Authors:  Shelina Moonsamy; Melinda Suchard; Shabir A Madhi
Journal:  PLoS One       Date:  2019-04-19       Impact factor: 3.240

8.  Neonatal vitamin A supplementation and immune responses to oral polio vaccine in Zimbabwean infants.

Authors:  James A Church; Sandra Rukobo; Margaret Govha; Marya P Carmolli; Sean A Diehl; Bernard Chasekwa; Robert Ntozini; Kuda Mutasa; Jean H Humphrey; Beth D Kirkpatrick; Andrew J Prendergast
Journal:  Trans R Soc Trop Med Hyg       Date:  2019-03-01       Impact factor: 2.184

9.  Serum and mucosal antibody responses to inactivated polio vaccine after sublingual immunization using a thermoresponsive gel delivery system.

Authors:  Jessica A White; Jeremy S Blum; Nancy A Hosken; Joshua O Marshak; Lauren Duncan; Changcheng Zhu; Elizabeth B Norton; John D Clements; David M Koelle; Dexiang Chen; William C Weldon; M Steven Oberste; Manjari Lal
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

10.  Immune responses to oral poliovirus vaccine in HIV-exposed uninfected Zimbabwean infants.

Authors:  James A Church; Sandra Rukobo; Margaret Govha; Marya P Carmolli; Sean A Diehl; Bernard Chasekwa; Robert Ntozini; Kuda Mutasa; Jean H Humphrey; Beth D Kirkpatrick; Andrew J Prendergast
Journal:  Hum Vaccin Immunother       Date:  2017-08-31       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.